Tuesday, July 29, 2014

Gilead Sciences - Barchart's Chart of the Day

Gilead Sciences (GILD) is the Barchart Chart of the Day.  The biopharmaceutical stock has a Trend Spotter buy signal, a Weighted Alpha of 54.20+ and gained 50.19% in the last year.

The Chart of the Day belongs to Gilead Sciences (GILD).  I found the stock by sorting today's New High list for new high frequency in the last month then used the Flipchart feature to review the charts.  Since the Trend Spotter signaled a buy on 6/26 the stock gained 13.28%.

GILD is an independent biopharmaceutical company that seeks to provide accelerated solutions for patients and the people who care for them. They have a broad-based focus on developing and marketing drugs to treat patients with infectious diseases, including viral infections, fungal infections and bacterial infections, and a specialized focus on cancer. They have expertise in liposomal drug delivery technology, a technology that the company uses to develop drugs that are safer, easier for patients to tolerate and more effective.

The status of Barchart's Opinion trading systems are listed below. Please note that the Barchart Opinion indicators are updated live during the session every 10 minutes and can therefore change during the day as the market fluctuates. The indicator numbers shown below therefore may not match what you see live on the Barchart.com web site when you read.

Barchart technical indicators:
  • 100% Barchart technical buy signals
  • Trend Spotter buy signal
  • Above its 20, 50 and 100 day moving averages
  • 13 new Hg's and up 12.00% in the last month
  • Relative Strength Index 69.94%
  • Barchart computes a technical support level at 89.24
  • Recently traded at 92.98 with a 50 day moving average of 84.32
Fundamental factors:
  • Market Cap $ 143.00 billion
  • P/E 18.80
  • Revenue expected to grow 113.10% this year and another 14.20% next year
  • Earnings estimated to increase 272.50% this year, an additional 19.20% next year and continue to increase at an annual rate of 27.25% for the next 6 years
  • Wall Street analysts issued 10 strong buy, 13 buy and 3 hold recommendations on the stock
Watch the 50 and 100 day moving averages and exit at he 100 day moving average.

No comments:

Post a Comment